SCM
CEMI

Stonepine Capital Management’s Chembio diagnostics, Inc. CEMI Stock Holding History

Stonepine Capital Management’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-147,011
Closed -$832K – 37
2018
Q4 		$832K Buy
+147,011
New +$1.08M 0.73% 18

Other funds holding CEMI

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
MAG
Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return

Stonepine Capital Management's CEMI Position: Q1 2019 in Review

Stonepine Capital Management sold out of Chembio diagnostics, Inc. (CEMI) in Q1 2019, closing a stake of 147,011 shares — an estimated $832K sold.

Stonepine Capital Management first reported a position in CEMI in Q4 2018 and held it in 1 quarter. The position peaked at $832K in Q4 2018. 39 funds tracked by Wall St. Rank hold CEMI as of Q1 2019.

  • Stonepine Capital Management reported no remaining Chembio diagnostics, Inc. position as of Q1 2019 after selling out during the quarter.
  • Stonepine Capital Management sold 147,011 Chembio diagnostics, Inc. shares in Q1 2019, an estimated $832K.
  • Stonepine Capital Management first reported a position in Chembio diagnostics, Inc. in Q4 2018 and held it in 1 quarter.
  • Stonepine Capital Management's Chembio diagnostics, Inc. position peaked at $832K in Q4 2018.
  • 39 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q1 2019.

Based on Stonepine Capital Management's 13F filing for Q1 2019, filed 14 May 2019.